Your browser doesn't support javascript.
loading
Reversible HER2 antibody-drug conjugate-induced ocular toxicity.
Sharma, Anushree; Riaz, Kamran M; Gill, Mohsain S; Patnaik, Amita; Ulahannan, Susanna V; Wang, Judy S; Gombos, Dan S; Ang, Qiuqing; Cicic, Dragan; Bergonio, Gregory R; Zhang, Cong; Wirostko, Barbara M.
Afiliação
  • Sharma A; Medical Center Ophthalmology Associates, San Antonio, Tex.
  • Riaz KM; Dean McGee Eye Institute, University of Oklahoma, Oklahoma City, Okla.. Electronic address: Kamran-Riaz@dmei.org.
  • Gill MS; University of Oklahoma Medical School, Oklahoma City, Okla.
  • Patnaik A; South Texas Accelerated Research Therapeutics, San Antonio, Tex.
  • Ulahannan SV; The University of Oklahoma Health Sciences Center/Sarah Cannon Research Institute, Oklahoma City, Okla.
  • Wang JS; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Fla.
  • Gombos DS; MD Anderson Cancer Center, Houston, Tex.
  • Ang Q; Klus Pharma, Inc, Cranbury, NJ.
  • Cicic D; Klus Pharma, Inc, Cranbury, NJ.
  • Bergonio GR; Klus Pharma, Inc, Cranbury, NJ.
  • Zhang C; Klus Pharma, Inc, Cranbury, NJ.
  • Wirostko BM; Moran Eye Center, University of Utah, Salt Lake City, Utah.
Can J Ophthalmol ; 57(2): 118-126, 2022 04.
Article em En | MEDLINE | ID: mdl-33727105
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article